N/A
N=2,778
You and Me COVID Free
COVID-19
Bottom Line
View on ClinicalTrials.gov: NCT05212883 ↗Enrolled (actual)
2,778
Serious AEs
—
Results posted
Jun 2023
Primary outcome: Primary: Main Reason for Testing for COVID-19 — 1632; 493; 238; 343 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Behavioral questionaires (Behavioral)
- Age
- Pediatric, Adult, Older Adult · 12+ yrs
- Sex
- All
- Sponsor
- Duke University
- Primary completion
- Mar 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Main Reason for Testing for COVID-19 |
1632; 493; 238; 343; 118; 152 | — |
| PRIMARY Number of Positive COVID-19 Test Results |
269 | — |
| PRIMARY Number of Participants Who Responded That They Have Received a COVID Vaccine |
850 | — |
| SECONDARY Number of Participants Who Indicated That They Have Access to Necessary Personal Protective Equipment in Work Place |
475 | — |
| SECONDARY Number of Participants Who Indicated They Have Tested Positive for COVID in Their Lifetime |
237 | — |
| SECONDARY Number of Participants Who Report Knowing Where to Get COVID-19 Tests in the Community |
757 | — |
| SECONDARY Number of Participants Who Report COVID Symptoms During Previous Week |
627 | — |
| SECONDARY Likelihood of Future COVID-19 Vaccination |
119; 140; 59; 92; 79 | — |
| SECONDARY Reasons for Not Getting a COVID-19 Vaccine |
5; 22; 3; 47; 7; 34 | — |
| SECONDARY Reasons for Getting a COVID-19 Vaccine |
712; 477; 557; 135; 86; 378 | — |
| SECONDARY Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications |
503; 526; 189; 1225; 209; 87 | — |
| SECONDARY Method Used to Test for COVID-19 |
783; 15; 4; 17; 2 | — |
Summary
Observational, study that distributes rapid at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communities.
Eligibility Criteria
Inclusion Criteria
- Self- reported primary residence within the pre-identified communities
- Age >12 years at enrollment
- Provision of signed and dated informed consent form
Exclusion Criteria
-None if above are met
Data sourced from ClinicalTrials.gov (NCT05212883). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.